Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
Abstract
Aim. To evaluate the pregnancy and delivery course, as well as fetal and newborn status, while achieving optimal blood pressure (BP) levels with different regimens of antihypertensive therapy (AHT) in pregnant women with chronic arterial hypertension (AH).
Material and methods. Starting from Trimester I, pregnant women received AHT, with dose titration and optimal BP achievement. Group I received chronic beta-adrenoblocker therapy (BAB), Group II – was administered BAB in Trimesters I and III, and calcium antagonists (CA) in Trimester II. Group III received CA in Trimesters I-III. The control group (CG) did not receive any AHT.
Results. Optimal BP levels were achieved more often in Group II. In Group III, inadequate BP control was linked to early gestosis. In CG, systolic and diastolic BP levels (SBB, DBP) were significantly higher. DBP was normalized more often than SBP. The minimal gestosis prevalence was observed in Group II (30%). Mean delivery terms in Group II were the latest, with the best newborn status by Apgar score and the lowest prevalence of delivery complications. The CG demonstrated the worst Apgar score parameters, due to hypoxia and ischemia of central nervous system in the newborns. Group I was characterised by prevalent respiratory distress syndrome in the newborns. Higher BP levels were generally associated with worse newborns’ functional status and lower mean body weight; however, in Group II, this association was not observed.
Conclusion. BP reduction to the optimal levels was safe and the most effective in rotation-based AHT (BAB+AC+BAB) among pregnant women with chronic AH.
About the Authors
N. G. Pivonova
Nizhny Novgorod State Medical Academy
Russian Federation
Nizhny Novgorod
Russian Federation
Nizhny Novgorod
I. V. Fomin
Nizhny Novgorod State Medical Academy
Russian Federation
Nizhny Novgorod
Russian Federation
Nizhny Novgorod
References
1. Даминова Л.А. Особенности течения артериальной гипертензии во время беременности и ее влияние на гестационный процесс и развитие плода. Дисс. канд. мед. наук. Уфа 2005.
2. Зозуля О.В. Течение гипертонической болезни у беременных. Механизмы развития, ранняя диагностика и профилактика осложнений. Дисс докт мед наук. Москва 1997.
3. Протопопова Н.В. Роль изменений метаболизма и гемодинамики в патогенезе осложнений беременности при артериальной гипертензии. Автореф дисс докт мед наук. Томск 1999.
4. Супряга О.М. Гипертензивные состояния у беременных: клинико-эпидемиологическое исследование: Автореф дисс докт мед наук. Москва 1997.
5. Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patient with mild chronic hypertension. Hypertens 1979; 53(4): 489-94.
6. August P, Lindheimer MD. Chronic hypertension and pregnancy. In Lindheimer MD, Roberts J,Cunningham FGC (eds). Chesley’s Hypertensive Disorders in pregnancy. Stamford,CT, Appleton&Lange,1999.
7. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. New Engl J Med 1992; 326: 927-32.
8. DeCherney AH, Nathan LA. Lange medical book. Current Obstetric and Gynecologic Diagnosis and Treatment. 9th Edition McGraw-Hill, 2003; 338 p.
9. Chauhan SP, Magann EF, Velthius S, et al. Detection of fetal growth restriction in patients with chronic hypertension: is it feasible? J Matern Fetal Neonatal Med 2003; 14(5): 324-8.
10. von Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. The Lancet 2000; 355: 87-92.
11. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1, 2002; 150-9.
12. Brown CA, Brown CA, Lee CT, et al. Maternal heart rate variability and fetal behavior in hypertensive and normotensive pregnancies Biol. Res Nurs 2008; 2: 134-44.
13. Mulrow CD, Chiquette E, Ferrer RL, et al. Management of chronic hypertension during pregnancy. Rockville, MD, USA: Agency for Healthcare Research and Quality. Evidence Report Tech Assess (Summ) 2000; 14: 208.
14. Page EW, Neff RK. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 1976; 125: 740-6.
15. Stimpel M. Arterial Hypertension. Berlin - New York, de Gruyter 1996; 356 p.
16. Roberts JM, Pearson GD, Cutler JA, et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003; 22(2): 109-27.
17. Thadhani RI, Johnson RJ, Karumanchi SA. Hypertension during pregnancy a disorder begging for pathophysiological support. Hypertension 2005; 46: 1250-1.
18. Magee LA, von Dadelszen P, Chan S, et al. The Control of Hypertension In Pregnancy Study pilot trial. Brit J Obstet Gynecol 2007; 114: 770-9.
19. Umans JG. Medications during pregnancy: antihypertensives and immunosuppressives. Adv Chronic Kidney Dis 2007; 2: 191-8.
20. Warland J, McCutcheon H, Baghurst P. Maternal blood pressure in pregnancy and stillbirth: a case-control study of third-trimester stillbirth. Am J Perinatol 2008; 25(5): 311-7.
Review
For citations:
Pivonova N.G., Fomin I.V. Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities. Cardiovascular Therapy and Prevention. 2009;8(8):19-24. (In Russ.)
Views:
509
Email this article 
